ISDE News

hank you to Prof. Theodore Liakakos, ESDE 2019 congress president, and the ESDE board for submitting this meeting review.

The ESDE 2019 congress was sucessfully held in Athens November 20-22, 2019.

Two pre-congress courses on minimally invasive esophagectomy and on endoscopy as well as the opening ceremony featuring the welcome addresses from Prof. Magnus Nilsson and Prof. Theodore Liakakos were held on the first day.

Updates on many “hot topics” were given by some of the most well-known international esophagologists.   Prof. John Reynolds, recently elected as ESDE General Secretary, gave the first “Christophe Mariette” lecture on “Multimodality Treatment in Esophageal Cancer”.

The congress official dinner was a unique experience at the Acropolis Museum. 

Watch the Discussion on Endoscopic Therapy in Barrett's Esophagus

Roundtable 4. Episode 3.

Barrett’s Esophagus is associated with long-term gastro-esophageal reflux disease (GERD) and is a risk factor for esophageal cancer. Current practice is to screen select patients who have multiple risk factors for esophageal cancer and monitor those patients diagnosed with Barrett's esophagus for development of precancerous change (dysplasia). Patients who are at higher risk of progressing to esophageal cancer may benefit from endoscopic therapy. 

An expert roundtable discussion on the management of Barrett’s Esophagus was recorded in three episodes during the 16th World Congress for Esophageal Diseases in Vienna, Austria. In Episode 3 our panelists discuss who should be treated, tools and skills required in endoscopic therapy, alternative therapies, the role of RFA, challenges, techniques and practices, other modalities and surveillance after treatment.

Thanks to our international panelists:

• Vani Konda, Baylor University Medical Center, USA
• Gary Falk, University of Pennsylvania Perelman School of Medicine Philadelphia, USA
• Prateek Sharma, University of Kansas School of Medicine and VA Medical Center, USA
• Peter Siersema, Radboud University Medical Center, Netherlands
• Kenneth Wang, Mayo Clinic Rochester, USA

Visit isde.net/barrett-esophagus for more information, resources and earlier episodes. 

EACSGE (Esophageal Adenocarcinoma Study Group Europe) Symposium

February 13-14, 2020 in Bologna, Italy

The first EACSGE (Esophageal Adenocarcinoma Study Group Europe) Symposium that will be held on February 13-14, 2020 at the Royal Hotel Carlton in Bologna, Italy, is a joined effort of the Universities of Bologna, Genova, Helsinki, of the Amsterdam University Medical Centers, and the National Oncologic IRST/IRCCS (Scientific Institute for Treatment and Research) of Meldola ( FC), Italy.

This first EACSGE Symposium will have a clear focus on the outcomes of disease biology and evolution; in addition, innovative study protocols, translational and early clinical studies on esophageal adenocarcinoma and Barrett’s esophagus will be presented.  Advanced Program.

The aim of the meeting is that discussion among eminent biologists, oncologists, pathologists, gastroenterologists and surgeons, will produce research programs aimed to identify new therapeutic strategies based on the identification of case by case biological patterns by means of bio-molecular prognostic and progression markers.

This multi-disciplinary meeting is offered to clinicians and scientists in the field of genomic medicine, pathology, gastroenterology, oncology and surgery with special interest in esophageal diseases.

Registration and information on abstract submission and deadline are available online. 

For detailed information, please visit: www.EACSGE.org

Register now: The deadline for Early Registration is December 10, 2019.

by Mark K. Ferguson
Department of Surgery, The University of Chicago, Chicago, IL, USA

Dr. David Skinner, the 4th President of the ISDE, was a world-renowned surgeon, educator, scholar, and leader. He participated in the formation of the ISDE, hosted two international congresses in 1983 and 1989, and made important advances in the ISDE during his presidential tenure 1992-1995.

Find out more about David Skinner's profile and research in his presidential biography.

The ISDE 2020 program committee prepared a highly engaging program including experts video sessions, mini-debates, pro-con sessions, case presentations and panel discussions, encouraging an active participation from the audience.

Take a look at the ISDE2020 Preliminary Program featuring the following topics:

• Management of Early Esophageal Cancer
• Plenary Video Session on a How I Do It Theme - Endoscopic & Surgical Topics
• Gastroesophageal Reflux
• Barrett’s Esophagus - Screening and Surveillance
• Barrett’s Esophagus – Endoscopic and Surgical Therapy
• Surgical Techniques in Esophageal Cancer
• Complications of Surgical and Endoscopic Interventions for Esophageal Disease
• Staging, Workup and Decision Making for Locally Advanced Esophageal Cancer
• Eosinophilic Esophagitis
• Treatment of Locally Advanced Esophageal Cancer - Neoadjuvant Therapy
• Esophageal Motility Disorders (Non-achalasia)
• Other Topics in Advanced Esophageal Cancer
• Large Hiatus Hernia / Paraesophageal Hernia
• Management of Esophageal Emergencies (Encourage Videos)
• Optimizing Outcomes for Esophageal Cancer - the Surgical Encounter – Winning at Both Ends?
• Achalasia

Make sure to be part of this highly engaging program and join us in Toronto, Canada, September 21-23, 2020.

Abstract submission will open in December 2019!

4th International Meeting of the Federation of Neurogastroenterology and Motility

March 24-29 in Adelaide Australia 

Dear Colleagues,

On behalf of the Australasian Neurogastroenterology and Motility Association (ANGMA), it is my pleasure to invite you to FNM 2020 which will take place in Adelaide, Australia March 24-29, 2020. We are delighted that ISDE has agreed to endorse this meeting.

FNM is the umbrella organization of international multidisciplinary societies dedicated to the study of motility disorders of the gastrointestinal tract, neurogastroenterology and functional gut disorders. ANGMA is delighted to be hosting the first such meeting held in the Southern Hemisphere.

This meeting will showcase research from surgeons, physicians and bench scientists and we have prepared an extensive multidisciplinary program which we hope you will find very interesting and informative.

Preceding the formal Scientific Program, there will be a strong Postgraduate Course which will provide a update of our field and will prove invaluable to our trainees. A masterclass in the POEM procedure will be held, and various satellite meetings will round off an exceptional week of science.  

Adelaide is famous for its outstanding wine, food and arts culture. The Convention Centre is in close proximity to many pristine beaches. FNM2020 will be held at the end of the Australian summer, providing the ideal climate to enjoy the meeting and the attractions that Adelaide and surrounding areas have to offer.

With the Australian dollar currently at a relatively low level, flights, accommodation and tourism can be remarkably inexpensive. We hope to be able to welcome you to Adelaide for FNM 2020. Please visit our web page for further information: www.fnm2020.org.au

Kind regards,

Dr Geoff Kohn MBBS, MSurg, FRACS, FACS
ANGMA President

Nick Spencer, PhD
Chair, Local Organizing Committee

Stuart Brierley, PhD
Co-Chair, Local Organizing Committee

Watch the Discussion on Assessment in Barrett’s Esophagus and Risks for Progression to Cancer

Roundtable 4. Episode 2.

Barrett’s Esophagus is associated with long-term gastro-esophageal reflux disease (GERD) and is a risk factor for esophageal cancer. Current practice is to screen select patients who have multiple risk factors for esophageal cancer and monitor those patients diagnosed with Barrett's esophagus for development of precancerous change (dysplasia). Patients who are at higher risk of progressing to esophageal cancer may benefit from endoscopic therapy.

An expert roundtable discussion on the management of Barrett’s Esophagus was recorded in three episodes during the 16th World Congress for Esophageal Diseases in Vienna, Austria. In Episode 2 our panelists discuss high quality exams and biopsy protocols, risks for progression to cancer, endoscopic enhanced imaging technologies, and more.

Thanks to our international panelists:

• Vani Konda, Baylor University Medical Center, USA
• Gary Falk, University of Pennsylvania Perelman School of Medicine Philadelphia, USA
• Prateek Sharma, University of Kansas School of Medicine and VA Medical Center, USA
• Peter Siersema, Radboud University Medical Center, Netherlands
• Kenneth Wang, Mayo Clinic Rochester, USA

Visit isde.net/barrett-esophagus for more information, resources and earlier episodes.

Listen to ISDE President, Prateek Sharma, discuss our latest achievements in the September/October Esophagram.

Watch the Discussion on Screening and Diagnosis for Barrett’s Esophagus

Roundtable 4. Episode 1.

Barrett’s Esophagus is associated with long-term gastro-esophageal reflux disease (GERD) and is a risk factor for esophageal cancer. Current practice is to screen select patients who have multiple risk factors for esophageal cancer and monitor those patients diagnosed with Barrett's esophagus for development of precancerous change (dysplasia). Patients who are at higher risk of progressing to esophageal cancer may benefit from endoscopic therapy.

An expert roundtable discussion on the management of Barrett’s Esophagus was recorded in three episodes during the 16th World Congress for Esophageal Diseases in Vienna, Austria. In Episode 1 our panelists discuss current challenges on screening for Barrett’s Esophagus, screening methods that are costly and not always accessible, standardization of endoscopic findings, effect of alternative and disruptive technologies, thoughts on improving screening criteria and methodologies.

Thanks to our international panelists:

• Vani Konda, Baylor University Medical Center, USA
• Gary Falk, University of Pennsylvania Perelman School of Medicine Philadelphia, USA
• Prateek Sharma, University of Kansas School of Medicine and VA Medical Center, USA
• Peter Siersema, Radboud University Medical Center, Netherlands
• Kenneth Wang, Mayo Clinic Rochester, USA

Visit isde.net/barrett-esophagus for more information and resources.

On behalf of the ISDE, Diseases of the Esophagus invites you to read the ISDE presidential biography of Joerg Ruediger Siewert written by Arnulf Hoelscher.

These biographies are being published as part of the celebration for the 40th anniversary of the first ISDE Congress during the upcoming 2020 ISDE Congress in Toronto. We hope you find the series an informative look at the history of the ISDE over the past 40 years.

Sincerely,
Giovanni Zaninotto and Neil Gupta
Editors in Chief, Diseases of the Esophagus (DOTE)

by Arnulf Hoelscher

J R Siewert’s clinical focus was oncological surgery, especially of the upper gastrointestinal tract but also functional, benign diseases of the esophagus and stomach. These were also the main subjects of his clinical research: refinements of the technique for esophageal and gastric surgery, prognostic factors of esophageal and gastric cancer, neoadjuvant therapy, and response prediction. The classification of adenocarcinomas of the esophagogastric junction in Type I, II, and III is combined with his name.

Read his full biography in Diseases of the Esophagus.